These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5655479)

  • 1. An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.
    Glazko AJ; Kinkel AW; Alegnani WC; Holmes EL
    Clin Pharmacol Ther; 1968; 9(4):472-83. PubMed ID: 5655479
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of the biological availability of chloramphenicol.
    Koeleman HA; Van Oudtshoorn MC
    S Afr Med J; 1973 Jan; 47(3):94-9. PubMed ID: 4631423
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of chloramphenicol activity, fate and absorption in different suspensions.
    Galal EE; Raggal MH; Kamel HH; Sabbagh H; Mahmoud MA; Azzam AB
    J Egypt Med Assoc; 1965; 48():Suppl:89-97. PubMed ID: 5873680
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on absorption kinetics of different brands of chloramphenicol.
    Lakshamana M; Seth SD; Shriniwas E; Arora RB
    Indian J Med Res; 1973 Jan; 61(1):138-44. PubMed ID: 4585703
    [No Abstract]   [Full Text] [Related]  

  • 5. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specificity of absorption and excretion of chloramphenicol in premature and newborn infants].
    Ura S
    Nihon Shonika Gakkai Zasshi; 1968 May; 72(5):697-705. PubMed ID: 5748795
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum levels and urinary excretion of chloramphenicol in the presence of isoniazid and salicylate.
    Mattila MJ; Takki S; Heino AE
    Ann Med Exp Biol Fenn; 1969; 47(3):203-8. PubMed ID: 5367516
    [No Abstract]   [Full Text] [Related]  

  • 8. Special characteristics of absorption and excretion of chloramphenicol in premature and newborn infants.
    Nishimura T; Kotani Y
    Bull Osaka Med Sch; 1970 Oct; 16(2):169-81. PubMed ID: 5511545
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects.
    Bel H; Johansen H; Lunde PK; Andersgaard HA; Finholt P; Midtvedt T; Holum E; Martinussen B; Aarnes ED
    Pharmacology; 1971; 5(2):108-20. PubMed ID: 5570924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of chloramphenicol on the mother and baby. II. Transfer, absorption, excretion and adverse effects of chloramphenicol in the newborn infant].
    Kunii K
    Jpn J Antibiot; 1970 Aug; 23(4):363-78. PubMed ID: 5312787
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of chloramphenicol metabolites and some factors affecting metabolic disposition.
    Glazko AJ
    Antimicrob Agents Chemother (Bethesda); 1966; 6():655-65. PubMed ID: 5985304
    [No Abstract]   [Full Text] [Related]  

  • 12. A pharmacologic study of chloramphenicol in cattle.
    Sisodia CS; Dunlop RH; Gupta VS; Taksas L
    Am J Vet Res; 1973 Sep; 34(9):1147-51. PubMed ID: 4747035
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of a chloramphenicol-rifampicin combination in rats].
    Cantelli Forti G; Fracasso ME
    Boll Soc Ital Biol Sper; 1971 Oct; 47(19):575-7. PubMed ID: 5140771
    [No Abstract]   [Full Text] [Related]  

  • 14. Excretion of chloramphenicol and its metabolites by the chronically diseased kidney (with respect to the theory of adaptive nephrons).
    Schück O; Prát V; Grafnetterová J; Kotanová E; Reitschlägerová V; David I
    Int J Clin Pharmacol; 1974 Jul; 10(1):33-43. PubMed ID: 4851956
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
    Watanabe A
    Pharmacology; 1974; 11(4):253-6. PubMed ID: 4156595
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic absorption of topically applied chloramphenicol eyedrops.
    Trope GE; Lawrence JR; Hind VM; Bunney J
    Br J Ophthalmol; 1979 Oct; 63(10):690-1. PubMed ID: 508680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampicillin, erythromycin and chloramphenicol penetration into rabbit aqueous humor.
    Goldman JN; Broughton W; Javed H; Lauderdale V
    Ann Ophthalmol; 1973 Feb; 5(2):147-56. PubMed ID: 4701066
    [No Abstract]   [Full Text] [Related]  

  • 18. Chloramphenicol metabolism in the phenobarbital-induced rat. Comparison with thiamphenicol.
    Bella DD; Marca G; Ferrari V; Bonanomi L
    Biochem Pharmacol; 1968 Dec; 17(12):2381-90. PubMed ID: 5720346
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
    Ambrose PJ
    Clin Pharmacokinet; 1984; 9(3):222-38. PubMed ID: 6375931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intraocular penetration of chloramphenicol succinate in rabbits.
    Broughton W; Goldman JN
    Ann Ophthalmol; 1973 Jan; 5(1):71-4 passim. PubMed ID: 4683788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.